More
    NewsChinaChina approves a fourth COVID-19 vaccine

    China approves a fourth COVID-19 vaccine

    China authorized the emergency use of a new COVID-19 vaccine developed by the director of its Center for Disease Control (CDC).

    Gao Fu, head of the Chinese CDC, led the development of a protein subunit vaccine, which the regulator licensed last week for emergency use, according to a statement released Monday by the Institute of Microbiology of the Chinese Academy of Sciences.

    It is the fourth vaccine to receive emergency clearance in the country. China has approved four vaccines developed by three Chinese companies for general use.

    The drug was jointly developed by Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. and the Chinese Academy of Sciences. The team completed phase one and two clinical trials in October last year and is now conducting the last phase of trials in Uzbekistan, Pakistan and Indonesia, according to the release.

    Read Also:   Fauci: U.S. going in wrong direction in fight against COVID

    The vaccine was approved for use in Uzbekistan on March 1.

    The protein subunit vaccine is similar to many of the other vaccines licensed in other countries in that it teaches the body to recognize the spicule glycoprotein that coats the surface of the coronavirus vaccine. The difference is in how it teaches the body to recognize it. Scientists grow a harmless version of the protein in cells and then refine it, before including it in the vaccine and injecting it into patients.

    Read Also:   Coronavirus: 11 new cases in China, the lowest figure since January

    There is no publicly available information in peer-reviewed scientific journals on the vaccine’s clinical data showing its efficacy or safety. A company spokesperson said the data would not be shared at this time, but that the firm was actively sharing data with health authorities.

    China is making slow progress in vaccinating its 1.4 billion population, despite having four vaccines licensed for general use. The latest data, according to a press conference held Monday in Beijing by government officials, is 64.98 million doses of vaccines administered.

    China has prioritized health, border and customs personnel, as well as workers in specific industries selected by the government. The second group, which had taken a back seat compared to many other countries, consists of the elderly and people with pre-existing diseases.

    Read Also:   what to do in case of itching and hair loss

    Vaccinations had initially been limited to adults between 18 and 59 years of age, as authorities said there was insufficient clinical data on older patients, although the government appears to be relaxing those limits. We will promptly complete mass vaccination of the relevant population, Li Bin, vice chairman of the National Health Commission, said Monday.

    Health centers in some Beijing neighborhoods began offering the vaccinations to people aged 60 and older last weekend, the official Xinhua news agency reported.

    Alex Dawit
    Alex Dawit
    Alex Dawit is Journalist of the Awutar. He had completed his graduation in Journalism and Communication, Pakistan. He is passionate about News, Blogging & Research Writing. You can contact him via: [email protected]

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Subscribe & Get Latest News

    FOLLOW US

    25,842FansLike
    341FollowersFollow
    641FollowersFollow
    349FollowersFollow
    1,887FollowersFollow
    4,213SubscribersSubscribe